3,286 results on '"Kawaoka, Yoshihiro"'
Search Results
202. Characterization of the SARS-CoV-2 B.1.621 (Mu) variant
203. Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants
204. Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine
205. Exploring mucosal immunization with a recombinant influenza virus carrying an HIV-polyepitope in mice with pre-existing immunity to influenza
206. Antiviral susceptibility of SARS-CoV-2 and influenza viruses from 3 co-infected pediatric patients
207. Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma
208. Designing Vaccines for Pandemic Influenza
209. Reverse Genetics Approach Towards Understanding Pathogenesis of H5N1 Hong Kong Influenza A Virus Infection
210. Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses
211. Transmission of Avian Influenza Viruses to Humans: Viral Receptor Specificity and Distribution in Human Airways
212. Host protein mimics viral protein to hinder infection by Ebola virus
213. Research article antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination.
214. Continued Circulation of Highly Pathogenic H5 Influenza Viruses in Vietnamese Live Bird Markets in 2018–2021.
215. Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual.
216. Influenza Viruses Suitable for Studies in Syrian Hamsters
217. Age-stratified seroprevalence of antibodies against SARS-CoV-2 in the pre- and post-vaccination era, February 2020–March 2022, Japan
218. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 clinical isolates
219. Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models.
220. Parsing the role of NSP1 in SARS-CoV-2 infection
221. Generation of Transgenic Mosquitoes Harboring a Replication-Restricted Virus
222. Isolation of bat sarbecoviruses of SARS-CoV-2 clade, Japan
223. Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron
224. Gain-of-Function Experiments on H7N9
225. Transmission Studies Resume For Avian Flu
226. Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates
227. A Syrian Golden Hamster Model Recapitulating Ebola Hemorrhagic Fever
228. Differences in Cytokine Production in Human Macrophages and in Virulence in Mice Are Attributable to the Acidic Polymerase Protein of Highly Pathogenic Influenza A Virus Subtype H5N1
229. Molecular Mechanisms Underlying Oseltamivir Resistance Mediated by an I117V Substitution in the Neuraminidase of Subtype H5N1 Avian Influenza A Viruses
230. Influenzavirus A : Orthomyxoviridae
231. Predicting host immune cell dynamics using tissue gene expression
232. Robustness of the Ferret Model for Influenza Risk Assessment Studies:a Cross-Laboratory Exercise
233. Defining the risk of SARS-CoV-2 variants on immune protection
234. Assembly of Immunogenic Protein Particles toward Advanced Synthetic Vaccines.
235. The Potential for Respiratory Droplet-Transmissible A/H5N1 Influenza Virus to Evolve in a Mammalian Host
236. Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters
237. Packaging of influenza virus genome: Robustness of selection
238. F1Fo-ATPase, F-type proton-translocating ATPase, at the plasma membrane is critical for efficient influenza virus budding
239. Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography
240. Pause on Avian Flu Transmission Research
241. Antibody Responses to a Reverse Genetics-Derived Bivalent Inactivated Equine Influenza Vaccine in Thoroughbred Horses
242. Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice
243. Multi-omics Characterization of Neutrophil Extracellular Trap Formation in Severe and Mild COVID-19 Infections
244. Immunological Correlates of Prevention of the Onset of Seasonal H3N2 Influenza
245. A 265-Nanometer High-Power Deep-UV Light-Emitting Diode Rapidly Inactivates SARS-CoV-2 Aerosols
246. Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2
247. Avian H7N9 influenza viruses are evolutionarily constrained by stochastic processes during replication and transmission in mammals
248. Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual
249. Efficacy of vaccination and previous infection against the Omicron BA.1 variant in Syrian hamsters
250. Characterization of H9N2 Avian Influenza Viruses Isolated from Poultry Products in a Mouse Model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.